Because the IL-23/IL-17 axis is an important pathway in psoriasis pathogenesis, we examined whether the loss of p32/C1qbp in hematopoietic cells inhibit the IL-23/IL-17-mediated pathogenesis of psoriasis-like dermatitis. Here, C1QBP is linked to skin disorder.